The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Combined chemoimmunotherapy of castrate-resistant prostate cancer with dendritic-cell based vaccine DCVAC/Pca.
Michal Podrazil
No relevant relationships to disclose
Daniela Rozkova
Employment or Leadership Position - Sotio
Jitka Fucikova
Employment or Leadership Position - Sotio
Stanislav Katina
No relevant relationships to disclose
Radek Spisek
Employment or Leadership Position - Sotio
Stock Ownership - Sotio
Research Funding - Sotio
Jirina Bartunkova
Employment or Leadership Position - Sotio
Stock Ownership - Sotio
Research Funding - Sotio